We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Court Dismisses Endo Suit, Opens Door to Generic Opana ER
Court Dismisses Endo Suit, Opens Door to Generic Opana ER
January 2, 2013
A Washington, D.C., district court judge has thrown out Endo Pharmaceuticals’ bid to prevent generic companies from producing the opioid drug Opana ER.